Shire acquired Dyax on January 21, 2016. Following this date, this page will no longer be actively monitored. There will be no updates or responses posted on this page. Please visit Shire's LinkedIn page at https://www.linkedin.com/company/shire or www.shire.com for more information.
| Website | http://www.dyax.com |
| Ticker | NASDAQ:DYAX |
| Revenue | $30.7 billion |
| Employees | 58 (43 on RocketReach) |
| Founded | 1989 |
| Address | 55 Network Drive, Burlington, Massachusetts 01803, US |
| Phone | +1 617-225-2501 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+36 more
(view full list)
|
| Industry | Biotechnology Research, Biopharma, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
| Web Rank | 543125 |
| Web Visits | 62930 |
| Keywords | Commercialization, Biotechnology, Pharmaceutical Products, Pharmaceutical, Therapeutics, Drug Development, Biologics, Protein Engineering, Clinical Trials, Drug Discovery, Biopharma, Life Sciences, Research, Healthcare, Innovation, Treatment, Medicine, Technology, Science, Manufacturing |
| Competitors | Roche, Novartis, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Vertex Pharmaceuticals, Biogen, Lilly India +48 more (view full list) |
Looking for a particular Dyax employee's phone or email?
The Dyax annual revenue was $30.7 billion in 2026.
Mark Sawyer is the Senior VP - Technical Operations of Dyax.
43 people are employed at Dyax.
Dyax is based in Burlington, Massachusetts.